LIPO
Lipella Pharmaceuticals Inc.Company with tickers: LIPO
CIK
1347242
CUSIP
53630L209
Shares Outstanding
4,620,837
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $216,117 | USD | 2025-09-30 | 10-Q | 2025-11-14 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $2,506,029 | USD | 2025-09-30 | 10-Q | 2025-11-14 |
| Operating Income | $-3,958,668 | USD | 2025-09-30 | 10-Q | 2025-11-14 |
| Net Income | $-3,888,087 | USD | 2025-09-30 | 10-Q | 2025-11-14 |
| EPS (Basic) | $-1.07 | USD/shares | 2025-09-30 | 10-Q | 2025-11-14 |
| EPS (Diluted) | $-1.07 | USD/shares | 2025-09-30 | 10-Q | 2025-11-14 |